Literature DB >> 16222206

Predictive factors of immediate postoperative complications after uvulopalatopharyngoplasty.

Jie Ae Kim1, Jeong Jin Lee, Hae Hyuk Jung.   

Abstract

OBJECTIVES/HYPOTHESIS: This study was performed to assess the relationships between polysomnographic data, including the level of obstruction inducing apnea, and immediate postoperative complications or oxygen saturation in patients who had undergone uvulopalatopharyngoplasty (UPPP) for obstructive sleep apnea syndrome (OSAS). STUDY
DESIGN: Retrospective study.
METHODS: Using the data of 90 patients with a polysomnography-confirmed diagnosis of OSAS who had undergone UPPP surgery with/without tonsillectomy under general anesthesia, we determined apnea-hypopnea indices (AHI), preoperative lowest arterial saturation (LSAT-PREOP) levels, percentages of obstruction at the upper level of the uvula during apnea (AL-U), need for an airway in the postanesthesia care unit (PACU) or during the first postoperative night in a ward (POPN1), LSAT- PACU, LSAT-POPN1, and the incidence of postoperative bleeding or other complications.
RESULTS: Postoperative complications developed in 19 (21.1%) of the 90 patients, airway-related complications in 5 (5.6%), oxygen desaturation in 8 (8.9%), excessive or recurrent bleeding in 7 (7.8%), and a postoperative electrocardiogram change in 1(1.1%). Patients with postoperative complications had higher AHI (68.1 vs. 49.3, P = .008), lower LSAT-PREOP (71.1 vs. 77.8, P = .012), and lower AL-U (24.2 vs. 57.4, P = .005) than those without. After UPPP surgery, LSAT-POPN1 improved more than LSAT-PREOP (94.4 vs. 76.2%, P = .03), and LSAT-POPN1 correlated with LSAT-PREOP (r = 0.274, P = .014) and AL-U (r = 0.286, P = .046).
CONCLUSIONS: This study shows that immediate postoperative complications and oxygen saturation are associated with OSAS severity and the level of obstruction, inducing apnea in those who have undergone UPPP for OSAS.

Entities:  

Mesh:

Year:  2005        PMID: 16222206     DOI: 10.1097/01.mlg.0000173199.57456.2b

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  7 in total

Review 1.  The management of surgical patients with obstructive sleep apnea.

Authors:  Jahan Porhomayon; Ali El-Solh; Sanjeev Chhangani; Nader D Nader
Journal:  Lung       Date:  2011-07-31       Impact factor: 2.584

2.  Postoperative complications in obstructive sleep apnea.

Authors:  M Jeffery Mador; Sandeep Goplani; V Anand Gottumukkala; Ali A El-Solh; Kumar Akashdeep; Ghana Khadka; Mohammed Abo-Khamis
Journal:  Sleep Breath       Date:  2012-07-21       Impact factor: 2.816

Review 3.  Effects and side-effects of surgery for snoring and obstructive sleep apnea--a systematic review.

Authors:  Karl A Franklin; Heidi Anttila; Susanna Axelsson; Thorarinn Gislason; Paula Maasilta; Kurt I Myhre; Nina Rehnqvist
Journal:  Sleep       Date:  2009-01       Impact factor: 5.849

4.  The incidence of early post-operative complications following uvulopalatopharyngoplasty: identification of predictive risk factors.

Authors:  Thileeban Kandasamy; Erin D Wright; John Fuller; Brian W Rotenberg
Journal:  J Otolaryngol Head Neck Surg       Date:  2013-02-06

5.  Comparison of postoperative bleeding between submucosal uvulopalatopharyngoplasty and tonsillectomy.

Authors:  Elif Ayanoglu Aksoy; Gediz Murat Serin; Senol Polat; Omer Faruk Unal; Hasan Tanyeri
Journal:  J Res Med Sci       Date:  2014-04       Impact factor: 1.852

Review 6.  Sleep Study and Oximetry Parameters for Predicting Postoperative Complications in Patients With OSA.

Authors:  Colin Suen; Clodagh M Ryan; Talha Mubashir; Najib T Ayas; Lusine Abrahamyan; Jean Wong; Babak Mokhlesi; Frances Chung
Journal:  Chest       Date:  2018-10-22       Impact factor: 9.410

7.  Surgical management of obstructive sleep apnoea: A position statement of the Australasian Sleep Association.

Authors:  Stuart G MacKay; Richard Lewis; Doug McEvoy; Simon Joosten; Nicolette R Holt
Journal:  Respirology       Date:  2020-11-15       Impact factor: 6.424

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.